|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
EP3515928B1
(en)
|
2016-09-23 |
2026-01-28 |
Duke University |
Unstructured non-repetitive polypeptides having lcst behavior
|
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
|
US12296018B2
(en)
|
2018-01-26 |
2025-05-13 |
Duke University |
Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
WO2020051541A1
(en)
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
CN113166783B
(zh)
|
2018-10-09 |
2024-10-11 |
不列颠哥伦比亚大学 |
包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
IL296763B2
(en)
|
2020-03-27 |
2026-04-01 |
Generation Bio Co |
New lipids and their nanoparticle compositions
|
|
KR20230172570A
(ko)
|
2021-04-20 |
2023-12-22 |
제너레이션 바이오 컴퍼니 |
양이온성 지질 및 이의 조성물
|
|
US12508225B2
(en)
|
2021-05-28 |
2025-12-30 |
Beijing Tricisionbio Therapeutics Inc. |
Lipid compound and use thereof in delivery of nucleic acid
|
|
WO2022266032A1
(en)
*
|
2021-06-14 |
2022-12-22 |
Generation Bio Co. |
Cationic lipids and compositions thereof
|
|
US20250281596A1
(en)
*
|
2021-09-28 |
2025-09-11 |
Seqirus Inc. |
Ionizable cationic compound
|
|
CN118201605A
(zh)
*
|
2021-10-25 |
2024-06-14 |
杜克大学 |
基于poegma的脂质纳米粒子
|
|
WO2023190166A1
(ja)
*
|
2022-03-28 |
2023-10-05 |
日油株式会社 |
ジスルフィド結合を有するカチオン性脂質、これを含む脂質膜構造体、これらのいずれかを含む核酸導入剤及び医薬品組成物、核酸を細胞又は標的細胞内へ導入する方法、及び細胞医薬品の製造方法
|
|
CN114685784B
(zh)
*
|
2022-04-26 |
2023-09-15 |
北京清科胜因生物科技有限公司 |
一种用于核酸递送的聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
|
|
EP4536197A1
(en)
*
|
2022-06-07 |
2025-04-16 |
Generation Bio Co. |
Lipid nanoparticle compositions and uses thereof
|
|
CN115105584B
(zh)
*
|
2022-06-28 |
2023-03-31 |
长春生物制品研究所有限责任公司 |
一种卡式瓶多剂量笔式注射组合包装的干扰素注射液
|
|
WO2024037577A1
(en)
*
|
2022-08-18 |
2024-02-22 |
Suzhou Abogen Biosciences Co., Ltd. |
Composition of lipid nanoparticles
|
|
EP4594299A1
(en)
*
|
2022-09-27 |
2025-08-06 |
Reinvigoron TheraTech, Inc. |
Compounds with cleavable disulfide moieties
|
|
CN120091992A
(zh)
*
|
2022-11-08 |
2025-06-03 |
三养控股公司 |
阳离子脂质及其制备方法
|
|
WO2024119103A1
(en)
|
2022-12-01 |
2024-06-06 |
Generation Bio Co. |
Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers
|
|
EP4704855A1
(en)
*
|
2023-04-26 |
2026-03-11 |
Saliogen Therapeutics, Inc. |
Lipid nanoparticle (lnp) formulations
|
|
US12311033B2
(en)
|
2023-05-31 |
2025-05-27 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025043146A2
(en)
*
|
2023-08-24 |
2025-02-27 |
Molecular Axiom Inc. |
Lipid nanoparticle compositions and methods of using same
|
|
WO2025064850A1
(en)
|
2023-09-22 |
2025-03-27 |
BioNTech SE |
Rna constructs with n-terminal degrons to enhance an immune response
|
|
WO2025106754A1
(en)
|
2023-11-15 |
2025-05-22 |
BioNTech SE |
Coronavirus vaccine
|
|
GB202416789D0
(en)
|
2023-11-15 |
2025-01-01 |
BioNTech SE |
SARS-COV-2 immunogenic compositions
|
|
WO2025149492A1
(en)
|
2024-01-08 |
2025-07-17 |
BioNTech SE |
Rna encoding an immune inhibitory il-1 family member
|
|
WO2025166238A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025178465A1
(ko)
*
|
2024-02-19 |
2025-08-28 |
주식회사 메디치바이오 |
신규한 이온화 지질 및 이를 이용한 지질 나노입자 조성물
|
|
WO2025230906A1
(en)
*
|
2024-04-29 |
2025-11-06 |
Saliogen Therapeutics, Inc. |
Lipid nanoparticle (lnp) formulations
|
|
WO2025237830A1
(en)
*
|
2024-05-15 |
2025-11-20 |
Evonik Operations Gmbh |
Polyoxyalkylene-1,2-di(alkyloxy)propanoxy-carbonylaminopropyl compounds, wherein the polyoxyalkylene is a poly(ethylene oxide) having c1 to c3-alkyloxymethyl side chains
|
|
WO2025255027A1
(en)
*
|
2024-06-03 |
2025-12-11 |
Flagship Labs 114, Inc. |
Lipid nanoparticles for topical delivery
|
|
WO2026047603A1
(en)
|
2024-08-28 |
2026-03-05 |
BioNTech SE |
Sars-cov-2 immunogenic compositions
|
|
WO2026057625A1
(en)
|
2024-09-11 |
2026-03-19 |
BioNTech SE |
Peptidoglycan hydrolases having a chap domain with engineered active site
|
|
WO2026057626A1
(en)
|
2024-09-11 |
2026-03-19 |
BioNTech SE |
Peptidoglycan hydrolases having multiple enzymatically active domains
|
|
WO2026068864A1
(en)
|
2024-09-30 |
2026-04-02 |
BioNTech SE |
Engineered ch1 and cl domains for the prevention of chain mispairing
|
|
CN121421963A
(zh)
*
|
2026-01-04 |
2026-01-30 |
广州隽沐生物科技股份有限公司 |
一种用于难溶性活性经皮黏膜给药的装配材料及制备方法
|